×
Home Current Archive Editorial board
News Contact
Research paper

Pseudothrombocytopenia induced by ethylenediaminetetraacetic acid: A case report

By
Dejan Dobrijević Orcid logo ,
Dejan Dobrijević
Nataša Kaćanski-Rađenović ,
Nataša Kaćanski-Rađenović
Jasmina Katanić ,
Jasmina Katanić
Jovanka Kolarović
Jovanka Kolarović

Abstract

Introduction: Pseudothrombocytopenia induced by ethylenediaminetetraacetic acid is a rare phenomenon caused by autoantibodies against platelet membrane with overall prevalence of 0.1% in the general population. This phenomenon is an in vitro artifact and with different anticoagulant used, the patient had the physiological platelet count. Case report: This case is a report of a 2-year-old patient, whose initial complete blood count analysis revealed low platelet count (18 x 10 9 /L) without any visible signs of hemorrhage. After detecting multiple platelet clumps in the peripheral blood smear, the complete blood count was repeated using 3.2% sodium-citrate. The analysis of the new specimen revealed the physiological platelet count. Thus, the patient was diagnosed with pseudothrombocytopenia induced by ethylenediaminetetraacetic acid. Conclusion: Pseudothrombocytopenia induced by ethylenediaminetetraacetic acid should always be suspected whenever thrombocytopenia without bleeding tendency is presented. The peripheral blood smear examination is the most convenient and the cheapest diagnostic test for excluding this artifact.

References

1.
Michelson AD. The Clinical Approach to Disorders of Platelet Number and Function. Platelets. 2019. p. 701–5.
2.
Prates RF, Viana RC, Oliveira MV, Souza CL. Pseudothrombocytopenia: incidence and strategy for resolution in clinical            laboratory. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2017;53(6).
3.
Lee AC wai. Pseudothrombocytopenia: What every clinician should know. Pediatrics & Neonatology. 2021;62(2):218–9.
4.
Zhong L, Chadha J, Ameri A. A Curious Case of Pseudothrombocytopenia due to In Vitro Agglutination. Case Reports in Hematology. 2020;2020:1–3.
5.
Lardinois B, Favresse J, Chatelain B, Lippi G, Mullier F. Pseudothrombocytopenia—A Review on Causes, Occurrence and Clinical Implications. Journal of Clinical Medicine. 10(4):594.
6.
Abal CC, Calviño LR, LR M. Pseudothrombocytopenia by ethylenediaminetetraacetic acid can jeopardize patient safety -a case report. Clin Chem Lab Med. 2020;31(1):65–9.
7.
Schuff-Werner P, Mansour J, Gropp A. Pseudo-thrombocytopenia (PTCP). A challenge in the daily laboratory routine? Journal of Laboratory Medicine. 2020;44(5):295–304.
8.
Sareen R, Kapil M, Gupta GN. Laboratory disease: Case of pseudothrombocytopenia. Int J Clinicopathol Correl. 2017;1:23–5.
9.
Reyes-Peña IM, Ávila-Zambrano JD, Villacrés-Mosquera LF. Pseudothrombocytopenia induced by ethylenediaminetetraacetic acid (EDTA. Rev Hematol Mex. 2019;20(2):142–5.
10.
Zhang L, Xu J, Gao L, Pan S. Spurious Thrombocytopenia in Automated Platelet Count. Laboratory Medicine. 2018;49(2):130–3.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.